Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo H Walczak, RE Miller, K Ariail, B Gliniak, TS Griffith, M Kubin, W Chin, ... Nature medicine 5 (2), 157-163, 1999 | 3120 | 1999 |
Fas ligand-induced apoptosis as a mechanism of immune privilege TS Griffith, T Brunner, SM Fletcher, DR Green, TA Ferguson Science 270 (5239), 1189-1192, 1995 | 2729 | 1995 |
Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells TS Griffith, WA Chin, GC Jackson, DH Lynch, MZ Kubin The Journal of Immunology 161 (6), 2833-2840, 1998 | 913 | 1998 |
CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death EM Janssen, NM Droin, EE Lemmens, MJ Pinkoski, SJ Bensinger, ... Nature 434 (7029), 88-93, 2005 | 830 | 2005 |
Intravascular staining for discrimination of vascular and tissue leukocytes KG Anderson, K Mayer-Barber, H Sung, L Beura, BR James, JJ Taylor, ... Nature protocols 9 (1), 209-222, 2014 | 730 | 2014 |
Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade Z Wang, EG Aguilar, JI Luna, C Dunai, LT Khuat, CT Le, A Mirsoian, ... Nature medicine 25 (1), 141-151, 2019 | 647 | 2019 |
TRAIL: a molecule with multiple receptors and control mechanisms TS Griffith, DH Lynch Current opinion in immunology 10 (5), 559-563, 1998 | 628 | 1998 |
Monocyte-mediated tumoricidal activity via the tumor necrosis factor–related cytokine, TRAIL TS Griffith, SR Wiley, MZ Kubin, LM Sedger, CR Maliszewski, NA Fanger The Journal of experimental medicine 189 (8), 1343-1354, 1999 | 620 | 1999 |
Human dendritic cells mediate cellular apoptosis via tumor necrosis factor–related apoptosis-inducing ligand (TRAIL) NA Fanger, CR Maliszewski, K Schooley, TS Griffith The Journal of experimental medicine 190 (8), 1155-1164, 1999 | 527 | 1999 |
CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. PM Stuart, TS Griffith, N Usui, J Pepose, X Yu, TA Ferguson The Journal of clinical investigation 99 (3), 396-402, 1997 | 475 | 1997 |
CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance TS Griffith, X Yu, JM Herndon, DR Green, TA Ferguson Immunity 5 (1), 7-16, 1996 | 474 | 1996 |
Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand M Ehtesham, P Kabos, MAR Gutierrez, NHC Chung, TS Griffith, KL Black, ... Cancer research 62 (24), 7170-7174, 2002 | 393 | 2002 |
The role of FasL-induced apoptosis in immune privilege TS Griffith, TA Ferguson Immunology today 18 (5), 240-244, 1997 | 350 | 1997 |
Functional analysis of TRAIL receptors using monoclonal antibodies TS Griffith, CT Rauch, PJ Smolak, JY Waugh, N Boiani, DH Lynch, ... The Journal of Immunology 162 (5), 2597-2605, 1999 | 341 | 1999 |
Antiinflammatory effects of CD95 ligand (FasL)-induced apoptosis Y Gao, JM Herndon, H Zhang, TS Griffith, TA Ferguson The Journal of experimental medicine 188 (5), 887-896, 1998 | 281 | 1998 |
CD8 T cells utilize TRAIL to control influenza virus infection EL Brincks, A Katewa, TA Kucaba, TS Griffith, KL Legge The Journal of Immunology 181 (7), 4918-4925, 2008 | 274 | 2008 |
Adenoviral-mediated transfer of the TNF-related apoptosis-inducing ligand/Apo-2 ligand gene induces tumor cell apoptosis TS Griffith, RD Anderson, BL Davidson, RD Williams, TL Ratliff The Journal of Immunology 165 (5), 2886-2894, 2000 | 270 | 2000 |
TNF-related apoptosis-inducing ligand (TRAIL): a new path to anti-cancer therapies PA Holoch, TS Griffith European journal of pharmacology 625 (1-3), 63-72, 2009 | 263 | 2009 |
Uptake of apoptotic antigen-coupled cells by lymphoid dendritic cells and cross-priming of CD8+ T cells produce active immune unresponsiveness TA Ferguson, J Herndon, B Elzey, TS Griffith, S Schoenberger, DR Green The Journal of Immunology 168 (11), 5589-5595, 2002 | 243 | 2002 |
Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis A Algeciras-Schimnich, TS Griffith, DH Lynch, CV Paya The Journal of Immunology 162 (9), 5205-5211, 1999 | 222 | 1999 |